Could FDG-PET imaging play a role in the detection of progressing atherosclerosis in HIV-infected patients?
Atherosclerosis
Fluorodeoxyglucose (FDG)
PET imaging
Journal
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
20
02
2018
accepted:
20
02
2018
pubmed:
10
3
2018
medline:
17
3
2020
entrez:
10
3
2018
Statut:
ppublish
Résumé
Important progresses in the management of patients with human immunodeficiency virus, in particular the advent of new anti-retroviral therapies (ART), have turned this rapidly fatal condition into a controllable chronic disease with a life expectancy that approaches the one from the general population. Cardiovascular diseases have now become one of the leading causes of non-HIV-related mortality in this population. Several factors including the presence of HIV in the vascular wall and the development of dyslipidemia and alteration in body fat distribution under ART might play a role the progression of atherosclerosis in HIV-infected patients. The use of imaging biomarkers may help to identify the factors associated with an increased risk of cardiovascular events and select high-risk patients who will benefit the most from the early implementation of preventive treatments.
Identifiants
pubmed: 29520571
doi: 10.1007/s12350-018-1247-2
pii: 10.1007/s12350-018-1247-2
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Editorial
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
1266-1268Commentaires et corrections
Type : CommentOn
Références
J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):441-9
pubmed: 11981359
J Clin Invest. 2003 Feb;111(3):389-97
pubmed: 12569165
Ann Intern Med. 2006 Sep 19;145(6):397-406
pubmed: 16983127
PLoS Biol. 2006 Oct;4(11):e365
pubmed: 17076584
J Am Coll Cardiol. 2006 Nov 7;48(9):1818-24
pubmed: 17084256
N Engl J Med. 2006 Nov 30;355(22):2283-96
pubmed: 17135583
N Engl J Med. 2007 Apr 26;356(17):1723-35
pubmed: 17460226
J Nucl Med. 2008 Jun;49(6):871-8
pubmed: 18483100
Circulation. 2008 Jul 8;118(2):e29-35
pubmed: 18566319
PLoS Med. 2008 Oct 21;5(10):e203
pubmed: 18942885
J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):268-73
pubmed: 19387353
J Nucl Med. 2009 Oct;50(10):1611-20
pubmed: 19759117
JAMA Intern Med. 2013 Apr 22;173(8):614-22
pubmed: 23459863
Nat Rev Immunol. 2013 Oct;13(10):709-21
pubmed: 23995626
Phys Med Biol. 2013 Nov 7;58(21):7527-42
pubmed: 24099932
JACC Cardiovasc Imaging. 2013 Dec;6(12):1250-9
pubmed: 24269261
J Nucl Med. 2015 Apr;56(4):552-9
pubmed: 25722452
Int J Cardiovasc Imaging. 2016 Jan;32(1):49-59
pubmed: 25898891
PLoS One. 2015 Jun 17;10(6):e0129550
pubmed: 26083524
JACC Cardiovasc Imaging. 2015 Aug;8(8):949-56
pubmed: 26189117
Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):780-92
pubmed: 26678270
J Nucl Cardiol. 2019 Aug;26(4):1258-1265
pubmed: 29417417